This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the potential of Abbott's Proclaim XR SCS system which was recently approved for the treatment of diabetic peripheral neuropathy.

Ticker(s): ABT

Who's the expert?

Institution: Center for Interventional Pain Spine

  • Anesthesiologist & Interventional Pain Management Specialist in private practice in PA; Founder of the Center for Interventional Pain Spine.
  • Familiar with Abbott's system and has implanted the device for diabetic peripheral neuropathy. 
  • Involved in clinical research with interest in integrative medicine, minimal invasive spine procedures, and neuromodulation approaches.

Interview Goal
This conversation will focus on the use of spinal cord stimulation systems for the treatment of diabetic peripheral neuropathy. We'll dig into the pros/cons of Abbott's Proclaim XR SCS system.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.